Ventus Medical
Ventus Medical LTD is a UK-based medical device developer building ENHALE, a CE-marked, low-temperature vaporisation nicotine inhaler for adult smokers and vapers seeking cessation, pending MHRA marketing authorisation.
- Company typePrivate
- Founded2015
- HeadquartersLiverpool, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Ventus Medical does
Ventus Medical LTD is a privately held UK medical device and pharmaceutical development company headquartered in Liverpool, founded in 2015 by David Lawson and Mark Dignum, both previously responsible for the world's first medically approved electronic cigarette (e-VOKE, MHRA-licensed in 2013) at Nerudia. The company has spent nine years developing ENHALE, a CE-marked electronic nicotine inhaler that delivers nicotine via proprietary low-temperature vaporisation through replaceable single-dose cartridges, avoiding the thermal degradants and metals associated with conventional vaping products.
ENHALE is positioned as the first innovation in licensed nicotine replacement therapy in over a decade and is intended to serve adult smokers and adult vapers seeking to reduce or quit nicotine consumption in the UK and, subsequently, Europe. The product has secured ISO 13485, ISO 9001, and ISO 14001 certifications from the British Standards Institution, and the company submitted a UK Marketing Authorisation Application to the MHRA in May 2024.
The business model centres on hardware sales of the ENHALE device and recurring cartridge replacement revenue, distributed through UK pharmacies and healthcare providers as a non-prescription product once MHRA approval is granted. The company is backed by Advent Life Sciences as its primary venture investor, with General Partner Kaasim Mahmood serving as Chairman. Ventus Medical is currently pre-revenue, with commercial launch contingent on regulatory approval.
Ventus Medical firmographics
Firmographics- Name
- Ventus Medical
- Legal name
- Ventus Medical LTD
- Website
- https://ventusmedical.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ventus Medical LTD is a UK-based medical device developer building ENHALE, a CE-marked, low-temperature vaporisation nicotine inhaler for adult smokers and vapers seeking cessation, pending MHRA marketing authorisation.
- Ownership category
- akta.pro rank
Ventus Medical industry classification
Industry- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro industry
- Smoking Cessation & Nicotine Replacement Therapy (NRT)Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories)Smoking Cessation & Nicotine Replacement Therapy (Gum, Patches, Lozenges)Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
Keywords
Where Ventus Medical is headquartered
LocationHeadquarters
- HQ city
- Liverpool
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Ventus Medical business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
Revenue model
- ENHALE Product Sales: Revenue from sale of ENHALE nicotine inhaler devices and replacement cartridges. Product will be available without prescription upon regulatory approval in the UK and subsequently Europe.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Ventus Medical product offering
Product offeringCore offering
Ventus Medical develops and markets ENHALE, a CE-marked medical device and electronic nicotine replacement therapy (NRT) inhaler that delivers nicotine through proprietary low-temperature vaporisation technology with replaceable single-dose nicotine cartridges. The product is designed for adult smokers and vapers seeking to reduce or quit nicotine consumption, providing safer nicotine delivery without thermal degradants or metals in the aerosol. The product is currently undergoing UK MHRA marketing authorisation review and will subsequently be submitted in Europe.
Product overview
Ventus Medical is a medical device and pharmaceutical development company offering a single unified product: ENHALE, a novel electronic nicotine replacement therapy inhaler. ENHALE is the company's principal development product and first innovation in licensed medicine in over a decade. It features proprietary low-temperature vaporisation technology and single-dose nicotine cartridges within a certified medical device, providing safer nicotine delivery compared to traditional vaping or smoking.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- ENHALE demonstrated to alleviate nicotine withdrawal symptoms quicker than leading NRT products whilst using less nicotine
Companies that use Ventus Medical
Customer profileSegments1 record
Ventus Medical technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Ventus Medical partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights4 records
Ventus Medical competitors and assessment
Company assessmentMarket position
Competitive moat3 records
Key highlights6 records
Customer concentration
Ventus Medical social profiles
Digital presenceVentus Medical compliance and trust
Trust signalCompliance5 records
Ventus Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ventus Medical leadership team
Management profileNumber of profiles
Ventus Medical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ventus Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ventus Medical
What does Ventus Medical do?
Ventus Medical develops and markets ENHALE, a CE-marked medical device and electronic nicotine replacement therapy (NRT) inhaler that delivers nicotine through proprietary low-temperature vaporisation technology with replaceable single-dose nicotine cartridges. The product is designed for adult smokers and vapers seeking to reduce or quit nicotine consumption, providing safer nicotine delivery without thermal degradants or metals in the aerosol. The product is currently undergoing UK MHRA marketing authorisation review and will subsequently be submitted in Europe.
Is Ventus Medical a public or private company?
Ventus Medical is a private company. It is currently operating.
When was Ventus Medical founded?
Ventus Medical was founded in 2015. It employs 11 to 50 people.
Where is Ventus Medical based?
Ventus Medical is headquartered in Liverpool, United Kingdom, in the Europe region.
How does Ventus Medical make money?
One revenue line is on record: ENHALE Product Sales.
Does Ventus Medical have an API?
No public API is recorded for Ventus Medical.
What industry is Ventus Medical in?
Its primary akta.pro industry code is HLAIADAH, Smoking Cessation & Nicotine Replacement Therapy (NRT), with a secondary code of HLAHAGAE, Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories). Its NAICS code is 339113 and its SIC code is 5047.